KEITH ANTHONY DELPRETE
Pharmacy in Coopersburg, PA
License number
Pennsylvania RP030573L
Category
Pharmacy
Type
Pharmacist
Address
Address
Coopersburg, PA 18036
Personal information
See more information about KEITH ANTHONY DELPRETE at radaris.comName
Address
Phone
4217 Mill Rd, Coopersburg, PA 18036
4217 Mill Rd, Coopersburg, PA 18036
4217 Mill Rd, Coopersburg, PA 18036
2235 Liberty St, Allentown, PA 18104
Professional information
Keith Delprete - Coopersburg, PA
Work:
DelCorean, LLC
CEO Medicap Pharmacy - Allentown, PA
Staff Pharmacist DelPrete's Pharmacy - Allentown, PA
Pharmacist Owner Carriage Drugs - Allentown, PA
Pharmacist, Manager, District Manager Thrift Drugs - Trexlertown, PA
Pharmacist, Assistant Manager Rea & Derrick
Pharmacy Intern
CEO Medicap Pharmacy - Allentown, PA
Staff Pharmacist DelPrete's Pharmacy - Allentown, PA
Pharmacist Owner Carriage Drugs - Allentown, PA
Pharmacist, Manager, District Manager Thrift Drugs - Trexlertown, PA
Pharmacist, Assistant Manager Rea & Derrick
Pharmacy Intern
Education:
Temple University - Philadelphia, PA
BS
BS
Transdermal Ricinoleic Acid Compositions
US Patent:
2010003, Feb 11, 2010
Filed:
Aug 6, 2008
Appl. No.:
12/186825
Inventors:
Keith Delprete - Coopersburg PA, US
International Classification:
A61K 9/127, A61K 31/20, A61K 33/38, A61K 33/34, A61K 33/32, A61K 33/26, A61K 33/06, A61K 33/04, A61P 25/06, A61P 19/02, A61P 25/16, A61P 31/10, A61P 31/04
US Classification:
424450, 514560, 424619, 424630, 424639, 424641, 424646, 424682
Abstract:
Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.
Transdermal Ricinoleic Acid Compositions
US Patent:
2012011, May 10, 2012
Filed:
Jan 17, 2012
Appl. No.:
13/351924
Inventors:
Keith Delprete - Coopersburg PA, US
International Classification:
A61K 31/201, A61P 11/00, A61P 17/04, A61P 31/04, A61P 17/02, A61P 17/00, A61P 17/12, A61P 21/00, A61P 1/16, A61P 25/06, A61P 25/00, A61P 29/00, A61K 33/34, A61K 33/32, A61K 33/04, A61K 33/00, A61K 33/30, A61K 33/24, A61K 33/26, A61K 33/38, A61K 9/127
US Classification:
424450, 514560, 424638, 424639, 424702, 424722, 424642, 424646, 424705, 424618
Abstract:
Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.
Topical Compositions With Long Lasting Effect
US Patent:
2008001, Jan 17, 2008
Filed:
Jul 10, 2007
Appl. No.:
11/775589
Inventors:
Keith DelPrete - Coopersburg PA, US
International Classification:
A61K 31/135, A61K 31/075, A61K 31/4015, A61K 31/407, A61K 31/42, A61K 31/444, A61K 31/485, A61K 31/5415, A61K 31/58, A61K 31/60, A61K 31/603, A61K 33/04, A61K 33/06, A61K 33/24, A61K 33/30, A61K 33/32, A61K 33/34, A61K 38/02, A61K 38/16, A61K 9/70, A61P 21/02, A61P 25/04, A61P 25/24, A61P 31/04, A61P 31/10, A61P 35/00, A61P 9/10, A61P 9/12
US Classification:
424449000, 424630000, 424639000, 424641000, 424646000, 424702000, 424722000, 514012000, 514165000, 514174000, 514002000, 514226500, 514282000, 514334000, 514378000, 514404000, 514413000, 514568000, 514653000, 514718000, 514789000
Abstract:
Topical pharmaceutical formulations and compositions for transdermal delivery of a variety of active agents are described. The formulations and compositions are formulated to provide a long lasting effect of the agent being delivered. The formulations and compositions of the present invention contain a transdermal vehicle and an adrenergic drug. The formulations and compositions may also contain guaifenesin.